Impact News +++ L&G to Start £1.2 Billion Share Buyback as Profit Climbs (Bloomberg) +++ LEGAL & GENERAL Aktie -3,33%

MICROBOT Aktie

>MICROBOT Aktienkurs

2.32 EUR +6.2% (TradegateBSX)

Ask: 2.314 EUR / 1363 Stück

Bid: 2.252 EUR / 1400 Stück

Tagesumsatz: 2530 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

MICROBOT Aktie über LYNX handeln

Intraday

1 Jahr

>MICROBOT Performance

1 Woche: +3,1%

1 Monat: +18,8%

3 Monate: +2,9%

6 Monate: -29,8%

1 Jahr: +69,1%

laufendes Jahr: +20,0%

>MICROBOT Aktie

Name:

MICROBOT MEDICAL DL-,01

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US59503A2042 / A2N5AS

Symbol/ Ticker:

CY9D (Frankfurt) / MBOT (NASDAQ)

Kürzel:

FRA:CY9D, ETR:CY9D, CY9D:GR, NASDAQ:MBOT

Index:

Webseite:

https://microbotmedical.c..

Profil:

Microbot Medical Inc. is a cutting-edge medical device company focused on enhancing healthcare through innovative technologies. The company's primary function is to develop micro-robotic medical solut..
>Volltext..

Marktkapitalisierung:

141.72 Mio. EUR

Unternehmenswert:

73.99 Mio. EUR

Umsatz:

EBITDA:

-12.03 Mio. EUR

Nettogewinn:

-11.26 Mio. EUR

Gewinn je Aktie:

-0.39 EUR

Schulden:

0.77 Mio. EUR

Liquide Mittel:

5.82 Mio. EUR

Operativer Cashflow:

-9.46 Mio. EUR

Bargeldquote:

27.34

Umsatzwachstum:

Gewinnwachstum:

-10.68%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

MICROBOT

Letzte Datenerhebung:

11.03.26

>MICROBOT Kennzahlen

Aktien/ Unternehmen:

Aktien: 67.16 Mio. St.

Frei handelbar: 90.86%

Leerverk. Aktien: 11.22%

Rückkaufquote: -52.61%

Mitarbeiter: 21

Umsatz/Mitarb.: -

Analysten:

Analystenrating: Strong buy

Kursziel: 228.1%

Bewertung:

KGV: -

KGV lG: -

KUV: -

KBV: 1.91

PEG-Ratio: -

EV/EBITDA: -

Rentabilität:

Bruttomarge: -

Gewinnmarge: -

Operative Marge: -

Managementeffizenz:

Gesamtkaprendite: -30.06%

Eigenkaprendite: -31.87%

>MICROBOT Peer Group

Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege

>MICROBOT Chart & Kurs - NASDAQ

>MICROBOT News

10.03.26 - 13:33	Microbot Medical® to Participate at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference for The First Time (GlobeNewswire EN)
	Microbot Medical® to Participate at the Oppenheimer 36th Annual Healthcare MedTech & Services Conference for The First Time...

04.03.26 - 14:33	Microbot Medical® Aligns with Recently Adopted Policy of the Largest U.S.-Based Medical Association to Expand Protection for Healthcare Professionals from Ionizing Radiation (GlobeNewswire EN)
	LIBERTY® Endovascular Robotic System's Capability to Reduce Radiation Exposure Appeals to Hospitals and Healthcare Providers LIBERTY® Endovascular Robotic System's Capability to Reduce Radiation Exposure Appeals to Hospitals and Healthcare Providers...

03.03.26 - 17:15	Microbot Medical says no impact from geopolitical events (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

03.03.26 - 15:03

Microbot Medical® Confirms Continued Operational and Commercial Stability Amid Current Geopolitical Event (GlobeNewswire EN)

HINGHAM, Mass., March 03, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced today that the Company, both in the USA and in Israel, is not experiencing any business disruption as a result of current geopolitical events. The safety and security of the employees remain its top priority. All personnel continue to operate as usual, and both internal operations and the lead manufacturing partner remain fully functional....

19.02.26 - 14:33	Microbot Medical®′s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference (GlobeNewswire EN)
	Microbot Medical®'s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference...

05.02.26 - 14:33	Microbot Medical® to Leverage Current Users Experience of the LIBERTY® Endovascular Robotic System at Key Oncology Conference to Support Commercial Adoption (GlobeNewswire EN)
	Microbot Medical® to Leverage Current Users Experience of LIBERTY® at Key Oncology Conference to Support Commercial Adoption....

26.11.25 - 14:33	Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System (GlobeNewswire EN)
	Microbot Medical® Announces Emory University Hospital as the First Hospital in the World to Adopt the New LIBERTY® Endovascular Robotic System...

05.11.25 - 15:54	Markteinführung von Robotiksystem beflügelt Aktie von Microbot Medical (Investing.com DE)
	Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...

05.11.25 - 14:33	Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S. (GlobeNewswire EN)
	Microbot Medical® Commences the Limited Market Release of its LIBERTY® Endovascular Robotic System in the U.S....

16.10.25 - 14:33	Microbot Medical® to Commercially Debut the LIBERTY® System at The Symposium on Clinical Interventional Oncology Annual Meeting (GlobeNewswire EN)
	First U.S. Based Medical Meeting Presence Post-FDA Clearance Will Allow the Company to Commercially Engage Future Potential Users of the LIBERTY® System...

14.10.25 - 15:00	Microbot Medical secures US-based logistics partner to commercialize LIBERTY system (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

14.10.25 - 14:33	Microbot Medical® Secures U.S. Based Logistics Partner to Support the Commercialization of Its LIBERTY® Endovascular Robotic System (GlobeNewswire EN)
	The Experienced MedTech Logistics Provider Will Help Ensure Effective and Efficient Inventory Management and Customer Support The Company is on Track to Commence the Launch of LIBERTY® during Q4 This Year...

07.10.25 - 14:03

Microbot Medical Announces Final Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds (GlobeNewswire EN)

$25.2 million in first closing, $1.2 million in second closing and $2.8 million in third and final closing, with up to an additional approximately $63 million of potential aggregate gross proceeds upon the exercise in full of short-term preferred investment options $25.2 million in first closing, $1.2 million in second closing and $2.8 million in third and final closing, with up to an additional approximately $63 million of potential aggregate gross proceeds upon the exercise in full of short-term preferred investment options...

01.10.25 - 15:03	Microbot Medical® Receives First Patent in Japan as it Continues to Broaden its Global Intellectual Property Portfolio (GlobeNewswire EN)
	Commercial Focus Remains on U.S. Market as it Continues to Explore Certain Global Markets that Accept FDA Cleared Devices ...

26.09.25 - 19:45	All You Need to Know About Microbot Medical (MBOT) Rating Upgrade to Buy (Zacks)
	Microbot Medical (MBOT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy)....

16.09.25 - 21:39

Microbot Medical Announces First Closing of Exercise of Outstanding Preferred Investment Options of Up to $92.2 Million in Gross Proceeds (GlobeNewswire EN)

$25.2 million in first closing and $4 million in second closing, with up to an additional approximately $63 million of potential aggregate gross proceeds upon the exercise in full of short-term preferred investment options $25.2 million in first closing and $4 million in second closing, with up to an additional approximately $63 million of potential aggregate gross proceeds upon the exercise in full of short-term preferred investment options...

15.09.25 - 14:03

Microbot Medical Announces Exercise of Outstanding Preferred Investment Options for Up to $92.2 Million in Gross Proceeds (GlobeNewswire EN)

09.09.25 - 21:15	Microbot Shares Rise on FDA Clearance for LIBERTY Robotic System (Zacks)
	MBOT shares rise as FDA clears its LIBERTY robotic system, paving the way for U.S. market entry and fueling strong investor momentum....

09.09.25 - 14:30	REMINDER: Microbot Medical to Highlight FDA 510(k) Clearance of the LIBERTY Endovascular Robotic System at the H.C. Wainwright Annual Investor Conference (GlobeNewswire EN)
	Live Presentation to be Webcast Today at 9am ET Live Presentation to be Webcast Today at 9am ET...

09.09.25 - 14:12	Microbot Medical share price jumps after FDA approval (Globes)
	The US Food and Drug Administration has granted clearance to Microbot Medical's Liberty endovascular robotic system....

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Wer alle Macht hat, muß auch alles fürchten. - Pierre Corneille

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram